本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

MEI Pharma

6.86
+0.31004.73%
盘前6.47-0.3900-5.69%05:04 EDT
成交量:193.86万
成交额:1,316.99万
市值:4,570.72万
市盈率:-1.44
高:7.47
开:6.84
低:6.26
收:6.55
数据加载中...
2023/10/03

重要事件披露

Form 8-K - Current report
2023/09/29

SEC问询函

Form CORRESP - Correspondence
2023/09/26

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/09/26

重要事件披露

Form 8-K - Current report
2023/09/22

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/18

SEC问询函

Form CORRESP - Correspondence
2023/09/16

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/08

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/07/28

重要事件披露

Form 8-K - Current report
2023/07/24

重要事件披露

Form 8-K - Current report
2023/07/20

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/07/20

重要事件披露

Form 8-K - Current report
2023/07/18

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/07/18

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/07/18

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/07/18

重要事件披露

Form 8-K - Current report
2023/07/18

重要事件披露

Form 8-K - Current report
2023/07/14

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/07/14

重要事件披露

Form 8-K - Current report